• News
  • Tech
    • DisruptiveTECH
    • ConsumerTech
    • How To
    • TechTAINMENT
  • Business
    • Telecoms
    • Mobility
    • Environment
    • Travel
    • StartUPs
      • Chidiverse
    • TE Insights
    • Security
  • Partners
  • Economy
    • Finance
    • Fintech
    • Digital Assets
    • Personal Finance
    • Insurance
  • Features
    • IndustryINFLUENCERS
    • Guest Writer
    • EventDIARY
    • Editorial
    • Appointment
  • TECHECONOMY TV
  • Apply
  • TBS
  • BusinesSENSE For SMEs
Monday, November 24, 2025
  • Login
No Result
View All Result
NEWSLETTER
Tech | Business | Economy
  • News
  • Tech
    • DisruptiveTECH
    • ConsumerTech
    • How To
    • TechTAINMENT
  • Business
    • Telecoms
    • Mobility
    • Environment
    • Travel
    • StartUPs
      • Chidiverse
    • TE Insights
    • Security
  • Partners
  • Economy
    • Finance
    • Fintech
    • Digital Assets
    • Personal Finance
    • Insurance
  • Features
    • IndustryINFLUENCERS
    • Guest Writer
    • EventDIARY
    • Editorial
    • Appointment
  • TECHECONOMY TV
  • Apply
  • TBS
  • BusinesSENSE For SMEs
  • Chidiverse
  • News
  • Tech
    • DisruptiveTECH
    • ConsumerTech
    • How To
    • TechTAINMENT
  • Business
    • Telecoms
    • Mobility
    • Environment
    • Travel
    • StartUPs
      • Chidiverse
    • TE Insights
    • Security
  • Partners
  • Economy
    • Finance
    • Fintech
    • Digital Assets
    • Personal Finance
    • Insurance
  • Features
    • IndustryINFLUENCERS
    • Guest Writer
    • EventDIARY
    • Editorial
    • Appointment
  • TECHECONOMY TV
  • Apply
  • TBS
  • BusinesSENSE For SMEs
  • Chidiverse
No Result
View All Result
Tech | Business | Economy
No Result
View All Result
  • News
  • Finance
  • StartUPs
  • TechTAINMENT
  • Guest Writer
  • Digital Assets
  • IndustryINFLUENCERS
  • Environment
  • Macro Monday
ADVERTISEMENT

Home » FundACause Partners with NSC to Raise ₦100m for Cancer Care

FundACause Partners with NSC to Raise ₦100m for Cancer Care

Cancer remains a major public health challenge in Nigeria, with an estimated 113.6 new cases per 100,000 persons and 74.6 cancer deaths per 100,000 persons per year

Destiny Eseaga by Destiny Eseaga
November 24, 2025
in Partners
Reading Time: 2 mins read
0
FundACause and NCS

L-r: Dr. Ishak Lawal, Chairman, Screening and Outreach Committee, Nigeria Cancer Society; Chris Ikechi, Business Development Executive, SystemSpecs Technology Services Limited (STSL); Prof. Ifeoma Okoye, Founder, Breast Without Spot; Prof. Abidemi Omonisi, President and CEO, Nigeria Cancer Society; Rachael Ukpebor, Business Development Executive, FundACause, STSL; and Abdullahi Sarki, Business Development Executive, STSL, at the Shield for Cancer fundraising initiative launch by the Nigeria Cancer Society, in partnership with FundACause, held recently in Abuja.

UBA
Advertisements
stanbic

FundACause, a digital fundraising platform in Nigeria, has partnered with the Nigeria Cancer Society (NCS) to launch the ‘Shield for Cancer’ fundraising campaign aimed at raising ₦100 million for the deployment of mobile cancer screening vans across all six geopolitical zones in Nigeria.

The campaign, which officially launched at the NAF Conference Centre, Abuja, on October 30, 2025, seeks to improve early cancer detection and treatment by extending screening services to rural and underserved communities, where access to diagnostic care remains limited and advanced cancer cases are most frequently reported.

Cancer remains a major public health challenge in Nigeria, with an estimated 113.6 new cases per 100,000 persons and 74.6 cancer deaths per 100,000 persons per year, according to Global Cancer Observatory (GLOBOCAN 2020).

ADVERTISEMENT

Although the country’s official 2018 – 2022 National Cancer Control Plan cites annual absolute figures of around 102,000 new cases and 72,000 deaths, more recent estimates suggest the burden is even higher, underscoring the urgent need for interventions that prioritise prevention and early detection.

Speaking at the launch, Prof. Abidemi Omonisi, president of the Nigeria Cancer Society, emphasised the significance of the initiative:

“Today marks a significant milestone in our collective effort to combat cancer in Nigeria, particularly within underserved rural communities.

“As a pathologist, I can attest that many of the advanced cancer cases we encounter originate from these areas, where access to early screening and preventive care is limited. This initiative is designed to bridge that gap.

“We are proud to partner with FundACause, developer of the fundraising platform to fight against cancer. The platform is now active, and we invite all Nigerians, philanthropists, government agencies, and the private sector to support this cause.”

MTN New

Developed by SystemSpecs Technology Services Limited (STSL), a subsidiary of SystemSpecs Group, the FundACause platform enables individuals, groups, and organisations to raise and donate funds towards verified causes in a transparent and secure digital environment. Its deployment for the Shield for Cancer campaign underscores SystemSpecs’ commitment to leveraging technology for social good.

Rachael Ukpebor, Business Development Executive at FundACause, reflected on the human impact of the initiative: “Across Nigeria, countless individuals receive life-altering cancer diagnoses every day. The emotional and financial toll on patients and their families is immense. Many are willing to fight but lack the resources to do so. FundACause bridges this gap by connecting verified fundraisers such as NCS with compassionate donors, enabling swift and secure support.”

“This initiative is deeply personal to us. We believe technology must play a central role in delivering hope and healing to those in need. As we launch the fundraising today, we invite everyone to join us in supporting the initiative. Together, we can create lasting impact,” she added.

The ₦100 million fund will be managed under strict governance structures, with oversight from a multi-stakeholder committee comprising cancer advocates, survivors, and healthcare professionals.

This ensures transparency and accountability while maximising the impact of every donation received.

By focusing on preventive care, rural outreach, and equitable access to healthcare, the Shield for Cancer campaign aims to reduce Nigeria’s high cancer mortality rate and foster a culture of community-driven health responsibility.

The campaign calls on citizens, private organisations, and government agencies to unite in reshaping the future of cancer care across the nation.

0Shares
stanbic
Destiny Eseaga

Destiny Eseaga

My name is Destiny Eseaga, a communication strategist, journalist, and researcher, deeply intrigued by the political economy of Nigeria and the broader world context. My passion lies in the world of finance, particularly, capital markets, investment banking, market intelligence, etc

Next Post
Bitget

This App Puts Stocks + Crypto in One Place - and Users Just Traded $5B+ in Stock Futures on it

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

I agree to the Terms & Conditions and Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

MTN New
UBA
Advertisements
  • About
  • Advertise
  • Careers
  • Contact Us

© 2025 TECHECONOMY.

No Result
View All Result
  • News
  • Tech
    • DisruptiveTECH
    • ConsumerTech
    • How To
    • TechTAINMENT
  • Business
    • Telecoms
    • Mobility
    • Environment
    • Travel
    • StartUPs
      • Chidiverse
    • TE Insights
    • Security
  • Partners
  • Economy
    • Finance
    • Fintech
    • Digital Assets
    • Personal Finance
    • Insurance
  • Features
    • IndustryINFLUENCERS
    • Guest Writer
    • EventDIARY
    • Editorial
    • Appointment
  • TECHECONOMY TV
  • Apply
  • TBS
  • BusinesSENSE For SMEs

© 2025 TECHECONOMY.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.